GAMA
ACIU icon

Graticule Asia Macro Advisors’s AC Immune ACIU Stock Holding History

Graticule Asia Macro Advisors’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-25,000
Closed -$412K – 101
2016
Q3 		$412K Buy
+25,000
New +$432K 0.03% 95

Other funds holding ACIU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Graticule Asia Macro Advisors's ACIU Position: Q4 2016 in Review

Graticule Asia Macro Advisors sold out of AC Immune (ACIU) in Q4 2016, closing a stake of 25,000 shares — an estimated $412K sold.

Graticule Asia Macro Advisors first reported a position in ACIU in Q3 2016 and held it in 1 quarter. The position peaked at $412K in Q3 2016. 19 funds tracked by Wall St. Rank hold ACIU as of Q4 2016.

  • Graticule Asia Macro Advisors reported no remaining AC Immune position as of Q4 2016 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 25,000 AC Immune shares in Q4 2016, an estimated $412K.
  • Graticule Asia Macro Advisors first reported a position in AC Immune in Q3 2016 and held it in 1 quarter.
  • Graticule Asia Macro Advisors's AC Immune position peaked at $412K in Q3 2016.
  • 19 funds tracked by Wall St. Rank held AC Immune as of Q4 2016.

Based on Graticule Asia Macro Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.